CryoCloud secures a 500k pre-seed investment to accelerate structure- based drug design with their cloud-native cryo-EM data analysis platform
We are happy to welcome our new portfolio company Cryocloud! Together with Nina Capital and ROM Utrecht Region we have invested € 500K to help the company in their mission to accelerate protein structure determination. We believe the company holds great promise to expand the use of CryoEM in drug development, with their
Ascencia raises seed capital investment for further development of their lab digitization technology
UTRECHT, Netherlands – Utrecht Health Seed Fund and imec.istart invest 300K+ euros in Ascenscia. Ascenscia is an emerging tech startup in laboratory automation. Their product comprises a highly specialized voice assistant for scientific laboratories. It understands scientific terminologies and workflows efficiently and enables scientists to communicate with other lab
Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept
Our new portfolio company Synerkine Pharma, a biopharmaceutical company creating innovative pain solutions. Leiden, the Netherlands, October 12, 2023 · Flerie leads Series A extension with other existing investor Thuja Capital participating and NEW investors InnovationQuarter Capital and Utrecht Health Seed Fund joining the round · Complementing the Series a
Academic Startup Competition – 4th Edition – APPLICATIONS OPEN
Dear Founder, We are excited to announce that the applications for the 4th edition of the Academic Startup Competition are open! The Academic Startup Competition (ASC) is a joint initiative of Techleap, UNL, NFU, NAE, UTwente, VU and EZK. The competition offers a curated batch of 20 selected academic startups
UMC Utrecht spin-out Cordys Analytics secures investment for improved early detection of heart disease.
UTRECHT, Netherlands – 3 oktober 2023 LUMO Labs, ROM Utrecht Region and Utrecht Health Seed Fund are investing 900,000 euros in Cordys Analytics. The startup is a Dutch healthtech spin-out from the University Medical Center Utrecht (UMCU) and incubated at UtrechtInc. Cordys Analytics’ AI-powered software platform for electrocardiogram analysis
Phlox Therapeutics Raises Additional Seed Funding to Further Develop RNA Therapies for Genetic Laminopathies
A very warm welcome to new portfolio company Phlox Therapeutics, a private biotechnology company specializing in developing innovative RNA-therapeutics for rare genetic cardiomyopathies. Below the press relaese; • Phlox Therapeutics raises additional seed funding to develop RNA therapies for genetic laminopathies • Funds will advance the company’s lead program into preclinical
Valentina Vignali appointed as Investment Associate
Utrecht Holdings welcomes Valentina Vignali to the team. Valentina is about to obtain a PhD in Biomedical Engineering from the University of Groningen and brings experience from working in academia and venture capital. At her previous roles she conducted fund and direct investments due diligence. Valentina will support the business
Looking for an Investment Analyst
Bringing new innovations to the market; that is the challenge that we, together with researchers from Utrecht University and UMC Utrecht, face every day at Utrecht Holdings. The goal of our team of 15 expert and enthusiastic employees, is to maximize the impact of academic research on people, society and
Nieuws
https://uhsf.nl/wp-content/uploads/2022/03/Cresco-2.png
360
360
anoukd@gel3t
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
anoukd@gel3t2022-06-27 11:18:232022-06-27 11:18:23Cresco Spine closes seed investments to develop innovative dynamic surgical therapy for scoliosis
https://uhsf.nl/wp-content/uploads/2022/02/Logo-Targed.jpg
360
360
anoukd@gel3t
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
anoukd@gel3t2022-02-22 09:52:132022-02-22 17:22:07TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients
https://uhsf.nl/wp-content/uploads/2021/09/foto-taart.png
623
629
anoukd@gel3t
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
anoukd@gel3t2021-09-03 12:42:052021-09-03 12:42:05Utrecht Health Seed Fund’s first anniversary!
https://uhsf.nl/wp-content/uploads/2021/05/sentryx_portfolio_tile.png
179
209
anoukd@gel3t
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
anoukd@gel3t2021-06-10 09:55:222021-11-01 15:53:30SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics
https://uhsf.nl/wp-content/uploads/2021/03/Targed-logo-360x360px.jpg
360
360
anoukd@gel3t
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
anoukd@gel3t2021-06-03 16:48:012021-06-03 16:48:01TargED Biopharmaceuticals appoints Ludo Haazen, M.D. as Chief Medical Officer
https://uhsf.nl/wp-content/uploads/2021/05/ntrans_portfolio_tile.png
179
209
anoukd@gel3t
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
anoukd@gel3t2021-05-28 10:39:432021-05-28 10:39:43NTrans Technologies closes Series A investment to accelerate development of gene editing therapy
https://uhsf.nl/wp-content/uploads/2021/03/Moveshelf1.png
1080
1920
admin
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
admin2021-03-02 17:09:122021-03-02 17:09:12Moveshelf closes seed investment to accelerate digital transformation of diagnosis and care for movement disorders
https://uhsf.nl/wp-content/uploads/2020/11/targed_news_tile.jpg
179
209
admin
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
admin2020-12-17 20:50:592020-12-19 16:51:27TargED receives NWO Take-Off 2
https://uhsf.nl/wp-content/uploads/2020/11/targed_news_tile.jpg
179
209
admin
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
admin2020-11-25 12:19:522020-11-25 12:49:09TargED closes seed investment and partners with UMC Utrecht for the development of Microlyse – a next-generation thrombolytic clot-busting drug
https://uhsf.nl/wp-content/uploads/2020/06/ROM_plaatje3.jpg
720
1280
admin
https://uhsf.nl/wp-content/uploads/2020/02/Logo-UHSF-homepage-1625x980_300dpi-300x181.png
admin2020-06-02 15:56:282020-06-02 16:19:04ROM Regio Utrecht Launched